4368-69-8 Usage
Derivative of 1,2,3-triazole
The compound is derived from the 1,2,3-triazole ring system, which is a five-membered ring containing three nitrogen atoms.
Nitrile functional group
The compound contains a nitrile functional group (CN), which is a carbon-nitrogen triple bond.
Synthesis of pharmaceuticals and agrochemicals
2-(1H-1,2,3-triazol-1-yl)acetonitrile is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals.
Building block in heterocyclic compound preparation
The compound is used as a building block in the preparation of heterocyclic compounds through various synthetic methods such as click chemistry.
Antiparasitic and anticancer properties
2-(1H-1,2,3-triazol-1-yl)acetonitrile has been investigated for its potential antiparasitic and anticancer properties.
Versatile and reactive
Due to its versatile nature and reactivity, this chemical has applications in a broad range of fields including medicinal chemistry, materials science, and chemical biology.
Check Digit Verification of cas no
The CAS Registry Mumber 4368-69-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,6 and 8 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4368-69:
(6*4)+(5*3)+(4*6)+(3*8)+(2*6)+(1*9)=108
108 % 10 = 8
So 4368-69-8 is a valid CAS Registry Number.
4368-69-8Relevant academic research and scientific papers
KINASE INHIBITORS
-
Paragraph 0468; 0469, (2013/03/26)
Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.
Novel pentafluorosulfanyl compounds
-
Page/Page column 21, (2010/02/13)
The present invention provides the compounds of formula I-A their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing th
Novel oxidized thioether derivatives
-
Page/Page column 19, (2010/02/13)
The present invention provides the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them
